NIT
MDGL icon

NumerixS Investment Technologies’s Madrigal Pharmaceuticals MDGL Stock Holding History

NumerixS Investment Technologies’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-400
Closed -$27K – 1203
2020
Q1 		$27K Sell
400
-100
-20% -$8.33K 0.01% 746
2019
Q4 		$46K Buy
+500
New +$48.5K 0.01% 832
2019
Q2 		– Sell
-2,000
Closed -$252K – 1233
2019
Q1 		$252K Buy
+2,000
New +$249K 0.03% 589
2018
Q4 		– Sell
-3,250
Closed -$690K – 1252
2018
Q3 		$690K Buy
+3,250
New +$816K 0.13% 225

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return